References
- Boring C C, Squires T S, Tong T. Cancer statistics, 1993. CA 1993; 43: 7–26
- Gamick M B. Prostate cancer: Screening, diagnosis and management. Ann Intern Med 1993; 118: 804–818
- Schaffer DL., Pendergrass H P. Comparison of enzyme, clinical, radiographic and radionuclide methods of detecting bone metasta-ses from carcinoma of the prostate. Radiology 1976; 121: 431–434
- Golimbu M, Morales P, Al-Askari S, Shulman Y. CAT scanning in staging of prostatic cancer. Urology 1981; 18(3)305–308
- Chybowski F M, Keller J JL, Bergstralh E J, Oesterling J E. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate specific antigen is superior to all other clinical parameters. J Urol 1991; 145: 313–318
- Oesterling J E, Martin S K, Bergstralh E J, Lowe F C. The use of prostate specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993; 269(1)57–60
- Hanks G E, Myers C E, Scardino P T. Cancer of the prostate. Cancer: Principles and Practice of Oncology, 4th ed, VT Devita, S Hellman, SA Rosenberg. J. P. Lippincott, Philadelphia 1993; 1073–1113